Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FDDS2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,605
Award facts
- Contract value 100% obligated
- $57,605.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,605.05 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, requires no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value through December 31, 2036.
DMS Pharmaceutical Group serves as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy, authorized to supply a comprehensive range of pharmaceutical products to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The company's established performance on numerous prior delivery orders, which have ranged from under $100 to over $115,000, demonstrates its operational capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system. As the sole awardee on this delivery order with no identified subcontractors, DMS Pharmaceutical Group will directly execute the pharmaceutical supply requirements for this transaction.
Quick answers
Who was awarded contract SPE2DR26FDDS2?
SPE2DR26FDDS2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FDDS2 worth?
The government has obligated $57,605 on SPE2DR26FDDS2.
Is contract SPE2DR26FDDS2 an order under another contract?
Yes. SPE2DR26FDDS2 is a delivery order under SPE2DR25D9102, an indefinite delivery contract.
Was contract SPE2DR26FDDS2 competed?
The extent of competition for SPE2DR26FDDS2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award